Skip to main content

Table 1 Patient demographics

From: Functional alterations of myeloid cells during the course of Alzheimer’s disease

Diagnosis CDR Number M,F Age, yr. ± SD
Control CDR 0 54 30, 24 69.81 ± 6.52
Prodromal AD CDR0.5 44 21, 23 73.57 ± 6.57
Mild AD Dementia CDR1 25 10, 15 74.48 ± 7.98
Moderate/Severe AD Dementia CDR2/3 28 9, 19 71.29 ± 8.52